Terlipressin

	WikiDoc Resources for Terlipressin
Articles
Most recent articles on Terlipressin Most cited articles on Terlipressin Review articles on Terlipressin Articles on Terlipressin in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Terlipressin Images of Terlipressin Photos of Terlipressin Podcasts & MP3s on Terlipressin Videos on Terlipressin
Evidence Based Medicine
Cochrane Collaboration on Terlipressin Bandolier on Terlipressin TRIP on Terlipressin
Clinical Trials
Ongoing Trials on Terlipressin at Clinical Trials.gov Trial results on Terlipressin Clinical Trials on Terlipressin at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Terlipressin NICE Guidance on Terlipressin NHS PRODIGY Guidance FDA on Terlipressin CDC on Terlipressin
Books
Books on Terlipressin
News
Terlipressin in the news Be alerted to news on Terlipressin News trends on Terlipressin
Commentary
Blogs on Terlipressin
Definitions
Definitions of Terlipressin
Patient Resources / Community
Patient resources on Terlipressin Discussion groups on Terlipressin Patient Handouts on Terlipressin Directions to Hospitals Treating Terlipressin Risk calculators and risk factors for Terlipressin
Healthcare Provider Resources
Symptoms of Terlipressin Causes & Risk Factors for Terlipressin Diagnostic studies for Terlipressin Treatment of Terlipressin
Continuing Medical Education (CME)
CME Programs on Terlipressin
International
Terlipressin en Espanol Terlipressin en Francais
Business
Terlipressin in the Marketplace Patents on Terlipressin
Experimental / Informatics
List of terms related to Terlipressin

Terlipressin
Clinical data
Routes of; administration	IV
ATC code	H01BA04 (WHO) ;
Pharmacokinetic data
Protein binding	~30%
Identifiers
	IUPAC name (2S)-1-[(4S,7S,10S,13S,16S,19S)-19-[[2-; [[2-[(2-Aminoacetyl)amino]acetyl]amino]; acetyl]amino]-13-benzyl-10-(2-carbamoylethyl)-; 7-(carbamoylmethyl)-16-[(4-hydroxyphenyl); methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,; 11,14,17-pentazacycloicosane-4-carbonyl]-N-; [(1S)-5-amino-1-(carbamoylmethylcarbamoyl); pentyl]pyrrolidine-2-carboxamide;
CAS Number	14636-12-5;
PubChem CID	72081;
DrugBank	EXPT03310;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C52H74N16O15S2
Molar mass	1227.37 g/mol

Terlipressin is an analogue of vasopressin used as a vasoactive drug in the management of hypotension. It has been found to be effective when norepinephrine does not help.

Indications for use include norepinephrine-resistant septic shock^[1] and hepatorenal syndrome.^[2] In addition, it is used in bleeding esophageal varices.^[3]
Terlipressin is marketed under the brand name Glypressin (Ferring Pharmaceuticals).

References

↑ O'Brien A, Clapp L, Singer M (2002). "Terlipressin for norepinephrine-resistant septic shock". Lancet. 359 (9313): 1209&ndash, 10. PMID 11955542.
↑ Uriz J, Ginès P, Cárdenas A, Sort P, Jiménez W, Salmerón J, Bataller R, Mas A, Navasa M, Arroyo V, Rodés J (2000). "Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome". J Hepatol. 33 (1): 43&ndash, 8. PMID 10905585.
↑ Ioannou G, Doust J, Rockey D. "Terlipressin for acute esophageal variceal hemorrhage". Cochrane Database Syst Rev: CD002147. PMID 12535432.

Template:Pituitary and hypothalamic hormones and analogues

Template:WikiDoc Sources

[OBrien-1] O'Brien A, Clapp L, Singer M (2002). "Terlipressin for norepinephrine-resistant septic shock". Lancet. 359 (9313): 1209&ndash, 10. PMID 11955542.

[Uriz-2] Uriz J, Ginès P, Cárdenas A, Sort P, Jiménez W, Salmerón J, Bataller R, Mas A, Navasa M, Arroyo V, Rodés J (2000). "Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome". J Hepatol. 33 (1): 43&ndash, 8. PMID 10905585.

[Ioannou-3] Ioannou G, Doust J, Rockey D. "Terlipressin for acute esophageal variceal hemorrhage". Cochrane Database Syst Rev: CD002147. PMID 12535432.

[1]

[2]

[3]

Terlipressin

See also

References

Navigation menu

Clinical data

Routes of administration	IV
ATC code	H01BA04 (WHO)
Pharmacokinetic data
Protein binding	~30%
Identifiers
IUPAC name (2S)-1-[(4S,7S,10S,13S,16S,19S)-19-[[2- [[2-[(2-Aminoacetyl)amino]acetyl]amino] acetyl]amino]-13-benzyl-10-(2-carbamoylethyl)- 7-(carbamoylmethyl)-16-[(4-hydroxyphenyl) methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8, 11,14,17-pentazacycloicosane-4-carbonyl]-N- [(1S)-5-amino-1-(carbamoylmethylcarbamoyl) pentyl]pyrrolidine-2-carboxamide
CAS Number	14636-12-5
PubChem CID	72081
DrugBank	EXPT03310
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₅₂H₇₄N₁₆O₁₅S₂
Molar mass	1227.37 g/mol